Efficacy of Treatment for Somatoform Disorders: A Review of Randomized Controlled Trials
The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To review the evidence from randomized clinical trials (RCTs) that have focused on the treatment of patients with Diagnostic and Statistical Manual of Mental Disorders, 4(th) Edition (DSM-IV) somatoform disorders. Although somatoform disorders are among the most common mental disorders presenting in the general medical setting, the strength of evidence for specific treatments has not been well synthesized. METHODS: MEDLINE search of articles published in English from 1966 to 2006, using the following search terms: randomized clinical trial, somatoform disorders, somatization disorder, undifferentiated somatoform disorder, hypochrondriasis, conversion disorder, pain disorder, and body dysmorphic disorder. RESULTS: A total of 34 RCTs involving 3922 patients were included. Two thirds of the studies involved somatization disorder (n = 4 studies) and lower threshold variants, such as abridged somatization disorder (n = 9) and medically unexplained symptoms (n = 10). Cognitive behavioral therapy (CBT) was effective in most studies (11 of 13), as were antidepressants in a small number (4 of 5) of studies. RCTs examining a variety of other treatments showed benefit in half (8 of 16) of the studies, the most consistent evidence existing for a consultation letter to the primary care physician. Effective treatments have been established for all somatoform disorders except conversion disorder (1 of 3 studies showing benefit) and pain disorder (no studies reported). CONCLUSION: CBT is the best established treatment for a variety of somatoform disorders, with some benefit also demonstrated for a consultation letter to the primary care physician. Preliminary but not yet conclusive evidence exists for antidepressants.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The PHQ-15: Validity of a New Measure for Evaluating the Severity of Somatic Symptoms
Kroenke, K., Spitzer, R. L., & Williams, J. B. W. (2002) · Psychosomatic Medicine · doi:10.1097/00006842-200203000-00008 · Cited by 3,298
Self-citationUtility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study
Spitzer, R. L. (1994) · JAMA · doi:10.1001/jama.272.22.1749 · Cited by 2,635
Effect Sizes for Interpreting Changes in Health Status
Kazis, L. E., Anderson, J. J., & Meenan, R. F. (1989) · Medical Care · doi:10.1097/00005650-198903001-00015 · Cited by 2,401 · cited 1×
“8 or greater are considered large therapeutic effects (61).”
BackgroundUtility of a New Procedure for Diagnosing Mental Disorders in Primary Care: The PRIME-MD 1000 Study
Spitzer, R. L. (1994) · JAMA · doi:10.1001/jama.1994.03520220043029 · Cited by 1,873
Summing up: The Science of Reviewing Research
Wilkinson, I., Light, R. J., & Pillemer, D. B. (1987) · Journal of Educational Statistics · doi:10.2307/1164691 · Cited by 1,471
Summing Up: The Science of Reviewing Research
Light, R. J., & Pillemer, D. B. (1984) · Harvard University Press eBooks · doi:10.4159/9780674040243 · Cited by 1,427
Barsky, A. J., Orav, E. J., & Bates, D. W. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.8.903 · Cited by 911
Medically Unexplained Physical Symptoms, Anxiety, and Depression: A Meta-Analytic Review
Henningsen, P., Zimmermann, T., & Sattel, H. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000075977.90337.e7 · Cited by 829
Ormel, E. A. (1995) · PsycEXTRA Dataset · doi:10.1037/e536912011-072 · Cited by 706
Cited by
Items 101–200 of 449
Lin, A., & Espay, A. J. (2021) · Epilepsy & Behavior Reports · doi:10.1016/j.ebr.2021.100469 · Cited by 36
“A 2007 systematic review of 34 RCTs, which involved somatoform disorders as well as functional disorders, found that CBT had a significantly greater effect size than antidepressants and behavioral therapy [12].”
BackgroundSchröder, A., Heider, J., Zaby, A., & Göllner, R. (2012) · Cognitive Therapy and Research · doi:10.1007/s10608-012-9474-3 · Cited by 49
“However, most of these studies merely compare CBT treatments with medical treatment as usual, or with WLC (Allen et al. 2002; Kroenke 2007; Looper and Kirmayer 2002; Nezu et al. 2001).”
BackgroundResultNeurocognitive functioning in patients with conversion disorder/functional neurological disorder
de Vroege, L., Koppenol, I., Kop, W. J., Riem, M. M. E., & Feltz-Cornelis, C. M. V. D. (2020) · Journal of Neuropsychology · doi:10.1111/jnp.12206 · Cited by 43
“A review of randomized controlled trials (Kroenke, 2007) reported only two randomized controlled trials (RCT) which explored the effect of hypnosis in patients with CD but showed limited effects (Moene, Spinhoven, Hoogduin, & Van Dyck, 2002; Moene, Spinhoven, Hoogduin, & Van Dyck, 2003 ).”
BackgroundPayne, H. (2009) · Body, Movement and Dance in Psychotherapy · doi:10.1080/17432970902918008 · Cited by 35
“In terms of the efficacy of treatment for somatoform disorders, Kroenke (2007) stated in his review of randomised controlled trials that ‘although somatoform disorders are among the most commonmental disorders presenting in the general medical setting, the strength of evidence for specific…”
BackgroundMedically Unexplained Symptoms
Isaac, M., & Paauw, D. S. (2014) · Medical Clinics of North America · doi:10.1016/j.mcna.2014.01.013 · Cited by 40
“Somatoform disorders are found inmore than one-fourth of patients with IEI symptoms and some investigators think that IEI may be a variant of MUS/somatoform disorders.8 Gulf War illness, which refers to a constellation of somatic symptoms in veterans of the Gulf War, is generally one of 2 types: chronic fatigue syndro…”
BackgroundInfluentialMental health in an age of austerity
Knapp, M. R. J. (2012) · Evidence-Based Mental Health · doi:10.1136/ebmental-2012-100758 · Cited by 53
“A review of trials concluded that CBT is effective.(12) The result is lower NHS costs (from reduced GP consultations, attendance at”
BackgroundLöwe, B., Piontek, K., Daubmann, A., Härter, M. C., Wegscheider, K., König, H., & Mora, M. C. S. (2017) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000491 · Cited by 35
Gierk, B., Kohlmann, S., Hagemann-Goebel, M., Löwe, B., & Nestoriuc, Y. (2017) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2017.07.002 · Cited by 33
Emerging themes in the revision of the classification of somatoform disorders
Creed, F., & Gureje, O. (2012) · International Review of Psychiatry · doi:10.3109/09540261.2012.741063 · Cited by 33
“Overall the studies have been positive but the evidence base for effi cacy is not strong (Creed et al., 2011b; Kroenke, 2007).”
BackgroundSolem, S., Borgejordet, S., Haseth, S., Hansen, B. K. A., Håland, Å. T., & Bailey, R. (2015) · Journal of Obsessive-Compulsive and Related Disorders · doi:10.1016/j.jocrd.2015.03.002 · Cited by 39
“Cognitive-behavioral therapy (CBT) is currently established as the leading treatment for health anxiety (Kroenke, 2007; Olatunji et al., 2014).”
BackgroundHyphantis, T. N., Tomenson, B., Paika, V., Almyroudi, A., Pappa, C., Tsifetaki, N., Voulgari, P. V., Drosos, A. A., Pavlidis, N. A., & Creed, F. H. (2009) · Quality of Life Research · doi:10.1007/s11136-009-9527-6 · Cited by 37
“It is increasingly recognized that we should measure depression and anxiety in the physically ill—a simple measure of somatization may be equally important, as there are recognized treatments that are effective in reducing somatization [ 63 ].”
Backgroundvan Ravesteijn, H. J., Suijkerbuijk, Y. B., Langbroek, J. A., Muskens, E., Lucassen, P. L., van Weel, C., Wester, F., & Speckens, A. E. M. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.04.010 · Cited by 47
“Several studies have shown modest improvements in somatic symptoms, psychological distress and functional impairment [6] [7] [8].”
BackgroundCollaborative stepped care for somatoform disorders: A pre–post-intervention study in primary care
Mora, M. C. S., Groß, B., Lau, K., Gumz, A., Wegscheider, K., & Löwe, B. (2015) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2015.11.004 · Cited by 36
O’Connell, N., Watson, G., Grey, C., Pastena, R., McKeown, K., & David, A. S. (2019) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.19030067 · Cited by 39
Ask, H., Waaktaar, T., Seglem, K. B., & Torgersen, S. O. (2015) · Research on Child and Adolescent Psychopathology · doi:10.1007/s10802-015-9977-y · Cited by 41
“treatment of any one disorder improves the symptoms of all three (Kroenke 2007; Mayou 2007).”
BackgroundZonneveld, L. N. L., van Rood, Y. R., Timman, R., Kooiman, C. G., Spijker, A. V., & Busschbach, J. J. V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042629 · Cited by 39
“It reduces UPS and concomitant psychological symptoms, improves daily functioning, and reduces financial expenses [13,14,15] without causing harmful effects [16].”
BackgroundHebert, C. L., Behel, J. M., Pal, G. D., Kasi, R. E., & Kompoliti, K. (2020) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2020.11.018 · Cited by 38
Early-Life Somatic Complaints: Longitudinal Associations with Maternal and Child Psychopathology
Engel, M. L., Winiarski, D. A., Reidy, B. L., & Brennan, P. A. (2018) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/dbp.0000000000000590 · Cited by 32
Toussaint, A. C., Hüsing, P., Kohlmann, S., Brähler, E., & Löwe, B. (2020) · Psychosomatic Medicine · doi:10.1097/psy.0000000000000903 · Cited by 31
“There is a wide range of empirically tested and beneficial interventions for these, mostly modifiable, psychological components (36).”
Treatment of Conversion Disorder in the 21st Century: Have We Moved Beyond the Couch?
Rosebush, P. I., & Mazurek, M. F. (2011) · Current Treatment Options in Neurology · doi:10.1007/s11940-011-0124-y · Cited by 33
“& There is no Class I evidence supporting the efficacy of any treatment for CD [21, 22 ]; indeed, most information is at the Class IV level—that is, expert opinion, case series, case reports, and open studies.”
BackgroundoVRcome – Self-guided virtual reality for specific phobias: A randomised controlled trial
Lacey, C. J., Frampton, C. M., & Beaglehole, B. (2022) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674221110779 · Cited by 35
“Depressive symptoms were assessed with the PHQ9 at baseline and week 6 (Kroenke, 2007).”
MethodBrooks, T., Sharp, R., Evans, S., Baranoff, J. A., & Esterman, A. (2020) · Journal of Pain Research · doi:10.2147/jpr.s223177 · Cited by 35
Vranceanu, A., Safren, S. A., Cowan, J., & Ring, D. (2010) · Psychosomatics · doi:10.1176/appi.psy.51.4.330 · Cited by 32
Body image and self‐esteem in somatizing patients
Sertöz, Ö. Ö., Baysal, Ö. D., & Elbi, H. (2009) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2009.01994.x · Cited by 40
Schmerler, D. A., & Espay, A. J. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-801772-2.00020-5 · Cited by 31
The recent surge of functional movement disorders: social distress or greater awareness?
Nilles, C., Pringsheim, T. M., & Martino, D. (2022) · Current Opinion in Neurology · doi:10.1097/wco.0000000000001074 · Cited by 32
“This form of CBT appears to be effective for psychiatric disorders, but further studies should determine their effectiveness in FND [34].”
BackgroundInfluentialAre Treatments for Common Mental Disorders Also Effective for Functional Symptoms and Disorder?
Mayou, R. (2007) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31815b00a6 · Cited by 30
Psychologic treatment of functional neurologic disorders
Goldstein, L. H., & Mellers, J. D. C. (2016) · Handbook of clinical neurology · doi:10.1016/b978-0-12-801772-2.00046-1 · Cited by 34
Scope, A., Leaviss, J., Booth, A., Sutton, A., Parry, G., Buszewicz, M., & Moss‐Morris, R. (2021) · British Journal of Health Psychology · doi:10.1111/bjhp.12521 · Cited by 18
“Pharmacological interventions have been shown to produce some improvement in patients in terms of symptom severity and functioning (Ford, Talley, Schoenfeld, Quigley, & Moayyedi, 2009; Hoedeman, Blankenstein, Krol, Koopmans, &Groothoff, 2010; Kroenke, 2007), although with significant heterogeneity of efficacy between…”
BackgroundVuokko, A., Selinheimo, S., Sainio, M., Suojalehto, H., Järnefelt, H., Virtanen, M., Kallio, E., Hublin, C., & Karvala, K. (2015) · NeuroToxicology · doi:10.1016/j.neuro.2015.04.010 · Cited by 27
Exploding myths about medically unexplained symptoms
Creed, F. H. (2016) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2016.02.007 · Cited by 30
Feltz-Cornelis, C. M. V. D., Brabyn, S., Ratcliff, J., Varley, D., Allgar, V. L., Gilbody, S. M., Clarke, C., & Lagos, D. (2021) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2021.100228 · Cited by 28
“…Kompoliti, 2015) to explore the underlying causes (such as historical trauma), occupational therapy, or physiotherapy (Nielsen et al., 2013) to help with any physical symptoms (Goldstein, 2020; Kroenke, 2007; Ruddy, 2005). ork.ac.uk (C. van der Feltz-Corne orm 15 February 2021; Accepted vier Inc.”
BackgroundMoreno, S., Gili, M., Magallón, R., Bauzá, N., Roca, M., del Hoyo, Y. L., & Garcia-Campayo, J. (2013) · Psychosomatic Medicine · doi:10.1097/psy.0b013e31829a8904 · Cited by 26
“Therefore, strong evidence supports the efficacy of CBT across several types of somatoform disorders (15).”
BackgroundTerminology, classification and concepts
Henningsen, P., Fink, P., Hausteiner‐Wiehle, C., & Rief, W. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977862.003 · Cited by 30
Pediatric Somatic Symptom and Related Disorders: Primary Care Provider Perspectives
Malas, N., Donohue, L. K., Cook, R. J., Leber, S. M., & Kullgren, K. A. (2017) · Clinical Pediatrics · doi:10.1177/0009922817727467 · Cited by 29
“Nearly half of the responding providers closely follow patients with SSRD longitudinally to maintain contact with patients and families, consistent with evidence-based practice recommendations.(1,3,16,17) This is an important finding given the critical role the PCP plays in ongoing recovery but is also an area of need…”
BackgroundOrzechowska, A., Maruszewska, P., & Gałecki, P. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10143159 · Cited by 37
“, hypochondriacal disorders, psychogenic pain)—which is clearly justified by research on its efficacy [39,40].”
BackgroundDessel, N. C.-V., Leone, S. S., van der Wouden, J. C., Dekker, J., & van der Horst, H. E. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.12.011 · Cited by 28
“This may be caused by the lack of knowledge about factors playing the most important role in influencing the course of MUPS [22–24].”
BackgroundA Randomized Trial of Treatments for High-Utilizing Somatizing Patients
BARSKY, A. J., Ahern, D. K., Bauer, M. R., Nolido, N. V., & Orav, E. J. (2013) · Journal of General Internal Medicine · doi:10.1007/s11606-013-2392-6 · Cited by 38
Intensive Multidisciplinary Treatment of Severe Somatoform Disorder: A Prospective Evaluation
Houtveen, J. H., van Broeckhuysen-Kloth, S., Lintmeijer, L. L., Bühring, M. E. F., & Geenen, R. (2015) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000250 · Cited by 24
“Once these skills have improved, the treatment focus shifts to acceptance (acceptance and commitment therapy [ACT]), cognitive-behavioral modulation (CBT), and involvement of the family system (systemic therapy).”
BackgroundResultInfluentialGoldstein, L. H., Robinson, E. J., Pilecka, I., Perdue, I., Mosweu, I., Read, J., Jordan, H., Wilkinson, M., Rawlings, G. H., Feehan, S. J., et al. (2021) · Health Technology Assessment · doi:10.3310/hta25430 · Cited by 30
Huijbregts, K. M. L., de Jong, F. J., van Marwijk, H., Beekman, A. T. F., Adèr, H. J., & Feltz-Cornelis, C. M. V. D. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2013.01.004 · Cited by 27
Behavioural and psychological management of somatic symptom disorders: An overview
Sharma, M. P., & Manjula, M. (2013) · International Review of Psychiatry · doi:10.3109/09540261.2012.746649 · Cited by 24
Psychiatric Disorders Associated with FXTAS
Seritan, A. L., Ortigas, M., Seritan, S., Bourgeois, J. A., & Hagerman, R. J. (2013) · Current Psychiatry Reviews · doi:10.2174/157340013805289699 · Cited by 29
Balabanovic, J., & Hayton, P. (2019) · Psychology and Psychotherapy Theory Research and Practice · doi:10.1111/papt.12213 · Cited by 27
“Relatively few randomised controlled trials have been conducted for this patient group and the majority conducted have focused on CBT-based interventions (Kroenke, 2007).”
BackgroundEffectiveness of a Multimodal Treatment Program for Somatoform Pain Disorder
Pieh, C., Neumeier, S., Loew, T. H., Altmeppen, J., Angerer, M., Busch, V., & Lahmann, C. (2013) · Pain Practice · doi:10.1111/papr.12144 · Cited by 24
“indeed been established for somatoform disorders in general, but not for conversion and somatoform pain disorder.(15) However, the treatment effect (standardized mean difference) ranges from 0.”
BackgroundYoshino, A., Okamoto, Y., Doi, M., Horikoshi, M., Oshita, K., Nakamura, R., Otsuru, N., Yoshimura, S., Tanaka, K., Takagaki, K., et al. (2015) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12330 · Cited by 25
“CBT is reported to be effective for the treatment of pain, negative affect, and adaptive functioning within the context of various somatoform disorders, including the DSM-IV categories of somatization disorder and hypochondriasis.(12) A meta-analysis by Koelen et al.”
BackgroundMonoamine system disruption induces functional somatic syndromes associated symptomatology in mice
Nagakura, Y., Ohsaka, N., Azuma, R., Takahashi, S., Takebayashi, Y., Kawasaki, S., Murai, S., Miwa, M., & Saito, H. (2018) · Physiology & Behavior · doi:10.1016/j.physbeh.2018.07.007 · Cited by 24
Emotion Regulation Strategies in Depression and Somatization Disorder
Davoodi, E., Wen, A., Dobson, K. S., Noorbala, A. A., Mohammadi, A., & Farahmand, Z. (2018) · Psychological Reports · doi:10.1177/0033294118799731 · Cited by 28
“Patients tend to describe minor automatic sensations in a catastrophic manner, which leads to elevated frequency of reported physical symptoms (Kroenke, 2007).”
BackgroundManabe, N., Tsutsui, H., Kusunoki, H., Hata, J., & Haruma, K. (2014) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.50.66 · Cited by 21
“1) Cognitive-behavioral therapy It has been reported that a cognitive-behavioral therapy was the best treatment for a variety of somatoform disorders and medically unexplained symptoms (57).”
BackgroundCognitive Behavioral Therapy for Psychogenic Neurological Disorders
Hopp, J. L., & LaFrance, W. C., Jr. (2012) · The Neurologist · doi:10.1097/nrl.0b013e31826e8ff5 · Cited by 27
“CBT has also been used to treat medically unexplained symptoms.(33,34,42) CBT is a form of psychotherapy that can be administered as a time-limited treatment to help a patient become aware of their dysfunctional thoughts and to maximize function by practicing new ways to think about their symptoms and learning new way…”
MethodManaging a patient with globus pharyngeus
Harvey, P., Theron, B., & Trudgill, N. J. (2017) · Frontline Gastroenterology · doi:10.1136/flgastro-2017-100844 · Cited by 21
Ali, S., Jabeen, S., Arain, A. M., Wassef, T., & Ibrahim, A. (2011) · PubMed · Cited by 20
Mari, J. D. J., Tófoli, L. F., Noto, C. D. S., Li, L. M., Diehl, A., Claudino, A. M., & Juruena, M. F. (2013) · Drugs · doi:10.1007/s40265-013-0113-4 · Cited by 23
“The evidence indicates that the efficacy of pharmacological agents for bodily distress disorders is poor, though data is sometimes scarce [69, 70].”
BackgroundConversion disorder in women with the FMR1 premutation
Seritan, A. L., Schneider, A., Olichney, J., Leehey, M. A., Akins, R. S., & Hagerman, R. J. (2009) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33054 · Cited by 20
“A review of randomized controlled trials for treatment of somatoform disorders showed evidence of successful outcomes for cognitivebehavioral therapy, as well as for antidepressants in a small number of studies [Kroenke, 2007].”
BackgroundSelf-compassion in somatoform disorder
der Ven, C. D.-V., Kloth, S. A. M., Thorsell, S., SCHOLTEN, R. G., Gucht, V. D., & Geenen, R. (2017) · Psychiatry Research · doi:10.1016/j.psychres.2017.12.013 · Cited by 27
“Meta-analyses have indicated that psychological treatment is beneficial for patients with somatoform disorder but that there is ample room for improvement of effects (Kroenke, 2007; Abbas et al., 2009; Kleinstäuber et al., 2011; Koelen et al., 2014).”
Backgroundvan Bronswijk, S. C., Lemmens, L. H. J. M., Huibers, M. J. H., & Peeters, F. P. M. L. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.09.135 · Cited by 26
Zonneveld, L. N. L., van Rood, Y. R., Kooiman, C. G., Timman, R., Spijker, A. V. ’., & Busschbach, J. J. V. (2012) · BMC Public Health · doi:10.1186/1471-2458-12-848 · Cited by 21
“Background Although Cognitive-Behavioral Therapy (CBT) is effective for Unexplained Physical Symptoms (UPS) [1-6], some therapists in clinical practice seem to believe that it is not equally effective for all patients with UPS.”
BackgroundImpact of Depression on 12-Month Outcomes in Primary-Care Patients with Chronic Musculoskeletal Pain
Kroenke, K., Wu, J., Bair, M. J., Damush, T. M., Krebs, E. E., & Tu, W. (2011) · Journal of Musculoskeletal Pain · doi:10.3109/10582452.2011.635844 · Cited by 20
Self-citationLind, A. B., Delmar, C., & Nielsen, K. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.07.015 · Cited by 24
“Cognitive behavioral therapy (CBT) is shown to be the best established treatment for varying somatoform disorders [47,48].”
BackgroundWhat’s Next for Somatic Symptom Disorder?
Dimsdale, J. E., & Levenson, J. L. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13050589 · Cited by 22
Huang, W.-L., Chen, T.-T., Chen, I.-M., Chang, L.-R., Lin, Y.-H., Liao, S.-C., & Gau, S. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.02.009 · Cited by 15
Current Validated Medical Treatments for Tinnitus
McKenna, L., Vogt, F., & Marks, E. M. (2020) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2020.03.007 · Cited by 21
The diagnosis and management of globus pharyngeus: our perspective from the United Kingdom
Karkos, P. D., & Wilson, J. A. (2008) · Current Opinion in Otolaryngology & Head & Neck Surgery · doi:10.1097/moo.0b013e328316933b · Cited by 19
Medically Unexplained Physical Symptoms
Jackson, J. L., George, S., & Hinchey, S. (2009) · Journal of General Internal Medicine · doi:10.1007/s11606-009-0932-x · Cited by 19
Poloni, N., Caselli, I., Ielmini, M., Mattia, M., Leo, A. D., Sarno, M. D., Isella, C., Bellini, A., & Callegari, C. (2019) · Behavioral Sciences · doi:10.3390/bs9070080 · Cited by 22
“We could not evaluate the eventual efficacy of any type of psychotherapy that presents some evidence of being effective [40,41] because this information was not available in the patients’ discharge letters.”
BackgroundA cognitive therapy program for hearing-impaired employees suffering from mental distress
Williams, K. C., Falkum, E., & Martinsen, E. W. (2014) · International Journal of Audiology · doi:10.3109/14992027.2014.958621 · Cited by 24
“Several studies indicate that disorder-specifi c forms of cognitive behavioral therapy (CBT) are useful not only for mental disorders, but also for somatic ailments (Harvey et al, 2007; Kroenke 2007; Sierpina et al, 2007).”
BackgroundBarriers to improving treatment
Henningsen, P., Fazekas, C., & Sharpe, M. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511977862.006 · Cited by 16
Functional Somatic Syndrome: Assessment and Management
Graver, C. J. (2017) · Journal of Osteopathic Medicine · doi:10.7556/jaoa.2017.101 · Cited by 18
“Osteopathic physicians, with their emphasis on holistic patient care, are in a key position to treat patients with FSS.”
BackgroundInfluentialInpatient psychosomatic treatment of anxiety disorders: comorbidities, predictors, and outcomes
Beutel, M. E., Bleichner, F., von Heymann, F., Tritt, K., & Hardt, J. (2011) · International Journal of Clinical and Health Psychology · Cited by 16
Gerger, H., Hlavica, M., Gaab, J., Munder, T., & Barth, J. (2015) · Psychotherapy and Psychosomatics · doi:10.1159/000380914 · Cited by 17
Heinbokel, C., Lehmann, M., Pohontsch, N. J., Zimmermann, T. P., Althaus, A., Scherer, M., & Löwe, B. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-014157 · Cited by 19
Feinstein, A. (2018) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000000601 · Cited by 26
Schenk, H., Bos, E. H., Slaets, J. P. J., de Jonge, P., & Rosmalen, J. G. M. (2017) · British Journal of Health Psychology · doi:10.1111/bjhp.12229 · Cited by 19
“Current treatments of somatoform disorders and FSS are often focused on reducing precipitating and perpetuating factors of somatic symptoms (Edwards, Stern, Clarke, Ivbijaro, & Kasney, 2010; Kroenke, 2007).”
BackgroundVerdurmen, M., Videler, A., Kamperman, A., Khasho, D., & van der Feltz-Cornelis, C. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s141208 · Cited by 15
Lai, H. H., North, C. S., Andriole, G. L., Cupps, L., Song, D., Ness, T. J., & Hong, B. A. (2013) · The Journal of Urology · doi:10.1016/j.juro.2013.12.031 · Cited by 15
Psychological therapy for psychogenic amnesia: Successful treatment in a single case study
Cassel, A., & Humphreys, K. (2015) · Neuropsychological Rehabilitation · doi:10.1080/09602011.2015.1033431 · Cited by 22
“Interestingly, there is an emerging evidence base for the efficacy of cognitive behavioural therapy (CBT) in the treatment of somatoform (Kroenke, 2007) and conversion disorders (LaFrance et al.”
BackgroundZonneveld, L. N. L., Spijker, A. V. ’., Passchier, J., Busschbach, J. J. V., & Duivenvoorden, H. J. (2009) · BMC Public Health · doi:10.1186/1471-2458-9-251 · Cited by 19
“Patients with UPS have high levels of psychosocial distress and healthcare utilization [5], for which cognitive behavioral therapy is shown to be most effective [6-9].”
BackgroundSeitz, T., Stastka, K., Schiffinger, M., Turk, B. R., & Löffler‐Stastka, H. (2019) · Bulletin of the Menninger Clinic · doi:10.1521/bumc_2019_83_01 · Cited by 16
Wortman, M. S. H., van der Wouden, J. C., Twisk, J. W. R., Visser, B., Assendelft, W. J., van der Horst, H. E., & Hartman, T. O. (2023) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2023.111178 · Cited by 15
Hubley, S. H., Uebelacker, L. A., & Eaton, C. B. (2014) · American Journal of Lifestyle Medicine · doi:10.1177/1559827614536865 · Cited by 19
“On the basis of a systematic review of treatments for somatic symptom and related disorders, 11 of 13 studies demonstrated statistically significant advantages of cognitive-behavioral therapy compared with a control condition.(16) Brief psychodynamic therapies,(58) mindfulness training,(59) and group therapy(60) also…”
ResultCognitive-Behavioral Therapy, Psychotherapy and Psychosocial Interventions in the Medically Ill
Balon, R. (2009) · Psychotherapy and Psychosomatics · doi:10.1159/000228246 · Cited by 15
“actually reviewed the evidence for the efficacy of 2 other interventions – antidepressants and other nonspecific intervention. The evidence for the efficacy of CBT was the strongest, though no study compared pharmacological and psychological treatments. In a similar review of randomized controlled trials, Kroenke [”
Unburdening the Difficult Clinical Encounter
Kroenke, K. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2008.548 · Cited by 14
Self-citationvan der Sluijs, J. V. E., ten Have, M., Rijnders, C. A. T., van Marwijk, H., de Graaf, R., & Feltz-Cornelis, C. M. V. D. (2016) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s109504 · Cited by 15
Rasmussen, N. H., Agerter, D. C., Colligan, R. C., Baird, M. A., Yunghans, C. E., & Cha, S. S. (2008) · PubMed Central · Cited by 16
Medically Unexplained Symptoms: Barriers to Effective Treatment When Nothing Is the Matter
Lipsitt, D. R., Joseph, R., Meyer, D. J., & Notman, M. T. (2015) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000055 · Cited by 17
Medically Unexplained Physical Symptoms: Why Counseling Psychologists Should Care About Them
McAndrew, L. M., Friedlander, M. L., Litke, D. R., Phillips, L. A., Kimber, J. M., & Helmer, D. A. (2019) · The Counseling Psychologist · doi:10.1177/0011000019888874 · Cited by 15
“This strategy has been shown to reduce medical costs and improve patients’ physical health outcomes because it results in fewer visits to urgent care facilities, a reduction in unnecessary hospitalizations, and less reliance on medications (Kroenke, 2007; Rost, Kashner, & Smith, 1994).”
BackgroundInfluentialPoovipirom, N., Ratta‐apha, W., Maneerattanaporn, M., Geeratragool, T., Chuenprapai, P., & Leelakusolvong, S. (2022) · Neurogastroenterology & Motility · doi:10.1111/nmo.14500 · Cited by 12
The BodyMind Approach™, medically unexplained symptoms and personal construct psychology
Lin, Y., & Payne, H. (2014) · Body Movement and Dance in Psychotherapy · doi:10.1080/17432979.2014.918563 · Cited by 12
“MUS are the most common current complaints in primary care (Kroenke, 2007).”
BackgroundDimsdale, J. E., & Creed, F. H. (2009) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2009.09.003 · Cited by 17
Hypochondriasis and Health‐Related Anxiety
Taylor, S., McKay, D., & Abramowitz, J. S. (2012) · Handbook of Evidence‐Based Practice in Clinical Psychology · doi:10.1002/9781118156391.ebcp002026 · Cited by 12
Zonneveld, L. N. L., Duivenvoorden, H. J., Passchier, J., & Spijker, A. V. ’. (2010) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.685 · Cited by 13
Nichtspezifische, funktionelle und somatoforme Körperbeschwerden: S3-Leitlinie und Patientenversion
Schaefert, R., Henningsen, P., Häuser, W., Herrmann, M., Ronel, J., Matzat, J., Sattel, H. C., & Hausteiner‐Wiehle, C. (2014) · Psychotherapeut · doi:10.1007/s00278-014-1030-z · Cited by 14
“W. Häuser hat in einem Advisory Board der Firma Daiichi Sankyo mitgearbeitet, erhielt Kostenerstattungen für Kongressbesuche und Reisen von der Falk Foundation und der Firma Eli Lilly und nichtproduktgebundene Vortragshonorare der Falk Foundation und der Firma Janssen-Cilag.”
BackgroundLaFrance, W. C., Jr. (2014) · Monographs in clinical neuroscience/Frontiers of neurology and neuroscience/Monographs in neural sciences · doi:10.1159/000360064 · Cited by 11
A prevention programme for somatoform disorders is effective for affective disorders
García‐Campayo, J., Arévalo, E., Claraco, L. M., Alda, M., & del Hoyo, Y. L. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.031 · Cited by 12
“Preliminary but not yet conclusive evidence exists for antidepressants (Kroenke, 2007; Sumathipatala, 2007).”
BackgroundSchmid, G., Dinkel, A., Henningsen, P., Dieterich, M., Hopfner, A., Pieh, C., & Lahmann, C. (2013) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2013.08.013 · Cited by 13
“Their bodily symptoms may then become chronic or exacerbated, leading them to seek additional medical help (“doctor-shopping”) and causing frustration and dissatisfaction on the part of both the patient and the physician [4,11,45–49].”
BackgroundMedically Unexplained Symptoms—A Perspective from General Practitioners in the Developing World
Husain, M. I., Duddu, V., Husain, M. O., Chaudhry, I. B., Rahman, R., & Husain, N. (2011) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.42.1.a · Cited by 11
“This view goes against the increasing evidence of effective treatments available for MUS [12, 19].”
BackgroundHealth care utilization of mexican patients with medically unexplained physical symptoms
González, A. M. R., Ramírez-Aranda, J. M., Reséndiz, H. D. L. S., Duarte, M. Y. L., Zanella, S. Ó. P., López, J. F. M., Alfaro, I. G., Ruz, F. G. I., Floriano, G. N., Salomón, E. G., et al. (2016) · Colombia medica · doi:10.25100/cm.v47i3.2102 · Cited by 11
Functional disorders: pathogenesis and systematic of clinical presentation
Diukova, G. M., Голубев, В. Л., Павлович, П. А., & Mnatsakanyan, M. G. (2016) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2016116121137-144 · Cited by 12
“Известно, что базовыми препаратами для лечения хронических болевых синдромов различной локализации являются антидепрессанты (АД) [57].”
Khoury, S., Piltonen, M., Ton, A., Cole, T., Samoshkin, A., Smith, S. B., Belfer, I., Slade, G. D., Fillingim, R. B., Greenspan, J. D., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25521 · Cited by 11
Kiese-Himmel, C. (2010) · HNO · doi:10.1007/s00106-009-2065-2 · Cited by 11
Metadata
- Authors
- Kroenke, K.
- Affiliations
- Regenstrief Institute (US)
- Corresponding author
- Kroenke, Kurt
- ORCID
- Kroenke, Kurt
- Venue
- Psychosomatic Medicine
- Published
- 2007-11
- Volume
- 69
- Issue
- 9
- Pages
- 881-888
- ISSN
- 0033-3174 (ISSN-L)
- OpenAlex
- W2004606740
- Cited by
- 450
- References
- 68
- Citations by year
- 2026: 7 · 2025: 17 · 2024: 10 · 2023: 4 · 2022: 13 · 2021: 14 · 2020: 16 · 2019: 20 · 2018: 25 · 2017: 39 · 2016: 26 · 2015: 22 · 2014: 40 · 2013: 48 · 2012: 41
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Psychosomatic Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Fibromyalgia and Chronic Fatigue Syndrome Research
- Keywords
- somatoform disorders, somatization disorder, medically unexplained symptoms, health anxiety, conversion disorder, pain disorders, body dysmorphic disorder, cognitive behavioral therapy, antidepressants, treatment efficacy
- MeSH terms
- Antidepressive Agents, Body Image, Combined Modality Therapy, Conversion Disorder, Delusions, Hypochondriasis, Primary Health Care, Somatoform Disorders, Cognitive Behavioral Therapy, Randomized Controlled Trials as Topic, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.